National Cancer Institute; Notice of Closed Meeting, 11248 [05-4498]
Download as PDF
<![CDATA[
11248
Federal Register / Vol. 70, No. 44 / Tuesday, March 8, 2005 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Health Professions Preparatory, Health
Professions Pregraduate and Indian
Health Professions Scholarship
Programs; Correction
ACTION:
Notice; correction.
SUMMARY: The Indian Health Service
published a document in the Federal
Register on January 19, 2005. The
document contained one error.
FOR FURTHER INFORMATION CONTACT: Mr.
Jess Brien, Chief, Scholarship Branch,
Indian Health Service, 801 Thompson
Avenue, Suite 120, Rockville, Maryland
20852; telephone 301–443–6197. (This
is not a toll-free number.)
Correction
In the Federal Register of January 19,
2005, in FR Doc. 05–1030, on page 3046,
in the second column, correct the
Application Review Date to read April
18–April 22, 2005.
Dated: February 28, 2005.
Robert G. McSwain,
Deputy Director, Indian Health Service.
[FR Doc. 05–4479 Filed 3–7–05; 8:45 am]
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Mary C. Fletcher, PhD,
Scientific Review Administrator, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, Rm 8115, Bethesda,
MD 20892, (301) 496–7413.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS.)
Dated: March 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–4498 Filed 3–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4160–16–M
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
E—Cancer Epidemiology, Prevention &
Control.
Date: April 6–8, 2005.
Time: 7 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
VerDate jul<14>2003
19:54 Mar 07, 2005
Jkt 205001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Sepsis and CAP:
Partnerships for Diagnostics Development.
Date: March 21–22, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Stefani T. Rudnick, PhD,
Scientific Review Administrator, Scientific
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, 301–496–2550,
srudnick@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Hepatitis C Cooeprative
Research Centers.
Date: March 23–25, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator,
Scientific Review Program, Division of
Extramural Activities, National Institutes of
Health/NIAID, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892–7616, 301–435–
2766, gm145a@nih.gov.
Name of Committee: National Institutes of
Allergy and Infectious Diseases Special
Emphasis Panel Novel HIV Therapeutics:
Integrated Preclinical/Clinical Program
(IPCP).
Date: March 23–25, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Silver Spring, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Tracy A. Shahan, PhD,
Scientific Review Adminsitrator, Scientific
Review Program, Divison of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
301–496–2606, tshahan@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Disorders of Therapeutic
Immunosuppression.
Date: March 23, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
3147, Bethesda, MD 20817, (Telephone
Conference Call).
Contact Person: Duane Price, PhD,
Scientific Review Administrator, NIAID,
DEA, Scientific Review Program, Room 2217,
6700B, Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, (301) 496–2550;
dprice@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Emphasis
Panel ‘‘Animal Models for the Prevention
and Treatment of Hepatitis B and Hepatitis
C.’’
Date: March 24, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Holiday Inn Chevy Chase, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Lucy A. Ward, DVM,
Scientific Review Administrator, Scientific
Review Program, Division of Extramual
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, Room 3117,
Bethesda, MD 20892–7616, (301) 496–2550;
lw275a@nih.gov.
E:\FR\FM\08MRN1.SGM
08MRN1
]]>Agencies
[Federal Register Volume 70, Number 44 (Tuesday, March 8, 2005)]
[Notices]
[Page 11248]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4498]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Initial Review
Group, Subcommittee E--Cancer Epidemiology, Prevention & Control.
Date: April 6-8, 2005.
Time: 7 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave.,
Bethesda, MD 20814.
Contact Person: Mary C. Fletcher, PhD, Scientific Review
Administrator, Research Programs Review Branch, Division of
Extramural Activities, National Cancer Institute, National
Institutes of Health, 6116 Executive Boulevard, Rm 8115, Bethesda,
MD 20892, (301) 496-7413.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS.)
Dated: March 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-4498 Filed 3-7-05; 8:45 am]
BILLING CODE 4140-01-M
